Reply: Pauling, et  al., Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis

This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatism - March 7, 2018 Category: Rheumatology Authors: Christopher P. Denton, Ariane L. Herrick Tags: Reply to Letter to the Editor Source Type: research